Effects of Dehydration on Neuromuscular Performance and Sympathetic Control of Cardiovascular Function

Dehydration Hypertonic Clinical Trial

Official title:

Effects of Dehydration on Neuromuscular Performance and Sympathetic Control of Cardiovascular Function

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03263975
• Other study ID #: 14-03H
• Status: Completed
• Phase: N/A
• Start date: October 31, 2014
• Est. completion date: December 1, 2017

Study information

• Verified date: April 2020
• Source: United States Army Research Institute of Environmental Medicine
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The mechanism(s) by which dehydration (both intra- and extracellular) impairs performance are still poorly described. A loss of volume results in increased occurrence of orthostatic intolerance, including dizziness, fatigue, headaches and related symptoms with upright posture. Any of these symptoms can contribute to decreased performance in maneuvers performed in the upright posture, which includes many military tasks. Thus, loss of volume challenges the cardiovascular and blood pressure responses to systemic whole body endurance exercise, while osmolality is the stimulus for intracellular dehydration that may impair local muscle force production by impairing contractile function, neural signaling, or both. In this study, we will compare how both types of dehydration affect MSNA and CAC.

The results of this study will provide mechanistic insight for how dehydration (intra- or extracellular) impairs systemic whole body and local small muscle performance in vivo. This Basic Science study seeks to understand how volume and osmolality impact MSNA and CAC as a basis for improving potential countermeasures, such as a more optimally formulated rehydration beverage. Therefore, this study directly complements Task Area T10 (Hot Weather Operations and Hydration: Injury and Performance Optimization) and impacts virtually all 14 Military Operational Medicine Research Program Drivers.

Description:

Study Objectives and Hypotheses

Primary Objective

The primary objectives of this study are to understand the in vivo effects of dehydration on:

1. Sympathetic neural control of cardiovascular function (MSNA), and

2. Neuromuscular function (CAC) via the IT Test

The primary hypotheses of this study are:

1. Baseline MSNA, and MSNA responses to tilt, will be higher in response to extracellular dehydration due to larger intravascular volume losses and greater baroreceptor unloading.

2. Neuromuscular function (CAC) via the IT Test will a) be more impaired by intracellular dehydration (cell stress) and b) CAC will show a greater performance reduction than CAR because it reduces the emphasis placed on the voluntary portion of performance (i.e., MVC).

Ancillary Questions/Sub Studies

1. The collection of blood and urine before and after exercise-heat stress and dehydration provides an opportunity to measure and characterize cytokine and intestinal barrier integrity marker (I-FAB, claudin-3) responses (blood) and renal stress biomarkers (urine) in humans. This descriptive research 'sub-study' directly complements Task Area T10 (Hot Weather Operations and Hydration: Injury and Performance Optimization) near and mid-term research goals of identifying biomarkers of heat stress for protection against heat injury. There are no hypotheses associated with this sub-study.

2. The study of dehydration requires rehydration for recovery. Rehydration provides an opportunity for a novel comparison of renal water retention (urine volume) when consuming equal volumes of two different commercial beverages (Gatorade® or Enterade-S®). Unlike Gatorade®, which is a carbohydrate-based beverage containing electrolytes, Enterade-S® is an amino acid-based beverage containing electrolytes. We hypothesize that the unique formulation of Enterade-S® will improve the rate of fluid absorption and fluid retention compared to Gatorade® in both intracellular and extracellular dehydration trials.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 43
• Est. completion date: December 1, 2017
• Est. primary completion date: December 8, 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• Male or female, age 18-45

• In good health as determined by OMSO General Medical Clearance

• Passed his/her most recent Army Physical Fitness Test (APFT) (military volunteers only) or exercise at least 2 times per week (civilian volunteers)

• Ability to comprehend and willingness to sign informed consent

Exclusion Criteria:

• Females who are pregnant or planning to become pregnant during the study

• Taking prescription or over the counter medication, other than a contraceptive (unless approved by OMSO and PI)

• Physical problems/injuries associated with walking or cycling

• Allergy to sulfa drugs (Lasix™ or sulfonamide antibiotics such as Septra™)

• Allergy to skin adhesive

• Hemoglobinopathy (sickle cell trait)

• Heart, lung, kidney, muscle, or nerve disorder(s)

• History of heat or orthostatic intolerance

• Diagnosed and/or treated for fluid/electrolyte imbalance within the last 30 days

• Presence of metal implants/electronic medical devices in lower extremities

• Current or previous (within the past 5 years) diagnosis of any autonomic disorder, including idiopathic orthostatic intolerance, orthostatic hypotension, postural tachycardia syndrome (POTS), or neurocardiogenic syncope (MSNA group only)

• Tobacco/nicotine use (MSNA group only)

• Significant muscle, joint, or bone injury affecting the legs within the last 6 months (CAC group only)

• Difficulty swallowing large pills

• History of obstructive disease of the gastrointestinal tract including (but not limited to) diverticulosis, diverticulitis and inflammatory bowel disease, peptic ulcer disease, Crohn's disease, ulcerative colitis; or previous gastrointestinal surgery.

Related Conditions & MeSH terms

• Dehydration
• Dehydration Hypertonic
• Isotonic Dehydration

Intervention

Other:
• Gatorade or Enterade
Commercially available oral rehydration therapies

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
United States Army Research Institute of Environmental Medicine

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Water and electrolyte retention	Mass balance measures of total body water and electrolytes	180 minutes
Secondary	Body water compartment changes	Osmometric measurements and calculations of body fluid spaces	180 minutes